1. Home
  2. DTSS vs NCNA Comparison

DTSS vs NCNA Comparison

Compare DTSS & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$0.92

Market Cap

9.0M

Sector

Technology

ML Signal

HOLD

Logo NuCana plc

NCNA

NuCana plc

HOLD

Current Price

$2.13

Market Cap

8.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTSS
NCNA
Founded
2014
1997
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0M
8.8M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
DTSS
NCNA
Price
$0.92
$2.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.7K
31.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$71,616,820.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
198.70
N/A
52 Week Low
$0.64
$0.03
52 Week High
$2.70
$10.00

Technical Indicators

Market Signals
Indicator
DTSS
NCNA
Relative Strength Index (RSI) 45.61 36.23
Support Level $0.81 $2.07
Resistance Level $0.98 $2.27
Average True Range (ATR) 0.09 0.14
MACD -0.00 0.05
Stochastic Oscillator 45.72 51.85

Price Performance

Historical Comparison
DTSS
NCNA

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Share on Social Networks: